[Fragility Fractures in Hemodialysis Patients. "Classical" osteoporosis in dialysis patients.]

Clinical calcium Pub Date : 2018-01-01 DOI:CliCa180810511056
Shozo Yano
{"title":"[Fragility Fractures in Hemodialysis Patients. \"Classical\" osteoporosis in dialysis patients.]","authors":"Shozo Yano","doi":"CliCa180810511056","DOIUrl":null,"url":null,"abstract":"<p><p>Previous studies demonstrated that patients undergoing chronic dialysis therapy showed several times higher risks for hip fracture compared to those of healthy subjects. Their bone tissue would be vulnerable because of the bone loss and poor quality. In addition, volume and strength of the muscle are decreased and the ratio of sarcopenia or frailty is increased among these patients, accordingly leading to higher risks for falls and bone fractures. Considering the pathophysiology of bone fracture in dialysis patients, it is a matter of course that one wonders how effective recently developed medicine for\"classical\" osteoporosis is. However, evidence to guide us is currently lacking. Therefore, it is crucial for us to construct evidence by observational and interventional studies.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"28 8","pages":"1051-1056"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical calcium","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/CliCa180810511056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Previous studies demonstrated that patients undergoing chronic dialysis therapy showed several times higher risks for hip fracture compared to those of healthy subjects. Their bone tissue would be vulnerable because of the bone loss and poor quality. In addition, volume and strength of the muscle are decreased and the ratio of sarcopenia or frailty is increased among these patients, accordingly leading to higher risks for falls and bone fractures. Considering the pathophysiology of bone fracture in dialysis patients, it is a matter of course that one wonders how effective recently developed medicine for"classical" osteoporosis is. However, evidence to guide us is currently lacking. Therefore, it is crucial for us to construct evidence by observational and interventional studies.

血液透析患者脆性骨折。透析患者的“经典”骨质疏松症。
先前的研究表明,接受慢性透析治疗的患者髋部骨折的风险是健康受试者的几倍。他们的骨组织会因为骨质流失和质量差而变得脆弱。此外,这些患者的肌肉体积和力量减少,肌肉减少或虚弱的比例增加,因此导致跌倒和骨折的风险更高。考虑到透析患者骨折的病理生理,人们当然想知道最近开发的治疗“经典”骨质疏松症的药物效果如何。然而,目前缺乏指导我们的证据。因此,通过观察性和干预性研究构建证据对我们来说至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信